M&A deals are often highly strategic and even transformative for a company -- they require experience and efficiency to maximize deal value. With unmatched experience leading on complex cross-border transactions, our seasoned M&A lawyers provide seamless advice through local expertise, deep sector knowledge, commercial acumen and refined transactional techniques to maximize deal certainty and the desired value and synergies of our clients’ transactions. We have been ranked #1 in cross-border deals by volume over the past decade by Refinitiv.
How We Can Help
Healthtech and Biotech M&A
The healthcare tech and biotech industries shifted fundamentally during the pandemic. Enthusiasm for dealmaking continues to be a growth area.
Tech M&A Outlook
After a pullback in tech M&A in 2022, and with IPO markets sluggish, dealmakers expect an uptick in M&A activity in 2023.
The M&A landscape has shifted this year to take account of more strategic concerns. Companies are focused on supply chain disruption, inflation and geopolitical unrest, creating interesting opportunities for buyers.